DRUGS MADE IN AMERICA ACQUISITION II CORP.: common_shares_outstanding
| Value | {"unit": "shares", "value": 13700000, "concept": "us-gaap:CommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2025-12-31) |
| Status | current |
| Entity | DRUGS MADE IN AMERICA ACQUISITION II CORP. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6f877f59-1d7d-4e62-a130-389f9659af5c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-044055Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0002040475/common-shares-outstanding/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6f877f59-1d7d-4e62-a130-389f9659af5c
History
- no predecessors — first report